Navigation Links
Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin

c cells. They also found that, just as embryonic cells have been shown to do, these adult stem cells produced both C-peptide, a part of the insulin precursor protein, and insulin itself. Confirming the presence of the C-peptide was especially crucial, the researchers suggested, because although insulin is often found in the growth media with which the cells are nurtured and is often taken up by such cells, the presence of the C-peptide proves that at least some of the insulin was produced, or synthesized, by the engineered cells.
'"/>

Source:University of Texas Medical Branch at Galveston


Page: 1 2 3

Related biology news :

1. New Finding May Aid Adult Stem Cell Collection
2. Adult stem cells aid recovery in animal model of cerebral palsy
3. Adult stem cells are touchy-feely, need environmental clues
4. Adult stem cell research at UB targets damaged hearts
5. Adults who go to bed lonely get stress hormone boost next morning
6. Wisconsin scientists grow critical nerve cells
7. Spleen may be source of versatile stem cells
8. Researchers discover way to make cells in the eye sensitive to light
9. Priming embryonic stem cells to fulfill their promise
10. Lack of enzyme turns fat cells into fat burners
11. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
Post Your Comments:
(Date:12/16/2009)... superstitions and rituals can help them get psyched up ... drugs (NSAIDs), which many athletes gobble down before and ... good. , "These agents are treatments for the symptoms ... Warden, whose research at Indiana University focuses on musculoskeletal ... to exercise or train at a certain level, but ...
(Date:12/16/2009)... our planet for more than 4 billion years before ... as many eons more. That suggests they may have ... Aviv University bacteria expert Prof. Eshel Ben-Jacob of the ... grounded in the study of bacteria, presents compelling evidence ... people should not automatically opt for the swine flu ...
(Date:12/16/2009)... of Medicine researcher will lead the coordinating center for ... the field of stem cell research. Michael L. Terrin, ... by the National Heart, Lung and Blood Institute (NHLBI) ... experts, which will be called the NHLBI Progenitor Cell ... a $30 million grant over seven years. , ...
Breaking Biology News(10 mins):NSAIDs: Take 'em early and often when competing? Think again 2Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3CMS Approves Press Ganey as a Qualified Home Health Care CAHPS Survey Vendor 58617 1CMS Approves Press Ganey as a Qualified Home Health Care CAHPS Survey Vendor 58617 2CMS Approves Press Ganey as a Qualified Home Health Care CAHPS Survey Vendor 58617 3Alcoholisms effect on sleep persists during long periods of sobriety 58616 1Alcoholisms effect on sleep persists during long periods of sobriety 58616 2Ulcerative colitis treatment reduces need for surgery by almost half 58614 1Ulcerative colitis treatment reduces need for surgery by almost half 58614 2
... of Standards and Technology (NIST) have demonstrated a ... studying individual proteins under conditions that mimic the ... individual proteins in nanodroplets of water, researchers can ... these biomolecules, says physicist Lori Goldner, a coauthor ...
... identified a gene variation in heart disease patients who appear ... to the point where blood flow to the heart is ... may be one way to better identify patients who are ... Sheps, M.D., a professor and associate chairman of cardiovascular medicine ...
... mothers who have allergies or asthma have an increased risk of ... before 6 months of age. This is shown in a ... (MoBa) at the Norwegian Institute of Public Health (NIPH). ... from MoBa. Approximately 25 percent of these children took part ...
Other Biology News:'Nanodrop' test tubes created with a flip of a switch 2Mental stress reduces blood flow to the heart in patients with gene variation 2Mental stress reduces blood flow to the heart in patients with gene variation 3Possible link between baby swimming and breathing problems in children 2
(Date:12/16/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, according to responses from surveyed ... (both interleukin inhibitors) will capture 22 percent of ... market for moderate to severe psoriasis. Among these ... nearly three times as much patient share as ...
(Date:12/16/2009)... Trial conducted pursuant to Special Protocol Assessment ... QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna ... AEZ) (the "Company"), a global biopharmaceutical company ... announced the initiation, by its partner Keryx ... Phase 3 registration clinical trial for perifosine ...
(Date:12/16/2009)... Nu-Tek BioSciences, LLC introduces HSP-A Soy Peptone. HSP A has ... , ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, ... by introducing HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, ... is proven to improve growth rates and yields. HSP-A has ...
(Date:12/15/2009)... The Joint BioEnergy Institute (JBEI), one of three Department ... AbsoluteProof trusted time-stamping service to protect its valuable intellectual ... ... Reston, VA (PRWEB) December 15, 2009 -- Surety, ... protection solutions , today announced that the Joint BioEnergy ...
Breaking Biology Technology:In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... Helminth infections are responsible,for a huge health ... drugs available to treat them is incredibly limited. ... helminth diseases has,necessitated a focused initiative to boost ... by the WHO Research and Training,in Tropical Diseases ...
... System delivers unmatched out-of-the-box functionality, BENSALEM, ... (Stelex), the market leader in providing enterprise-wide,compliance ... the,Quality Management System (QMS) module for Livelink ... provider of Enterprise Content,Management (ECM) software and ...
... global leader in radiation,oncology and non-invasive neurosurgery solutions, ... Annual Meeting of The American Society for,Therapeutic Radiology ... increase efficiency. The meeting will be held October,28 ... Center (Los Angeles,California, USA). Elekta will showcase innovative ...
Other Biology Technology:WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery 2Stelex Announce QMS Module for Open Text's Livelink ECM 2Stelex Announce QMS Module for Open Text's Livelink ECM 3Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 2Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 3Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007 4
...
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
Marmoset plasma and serum - various quantities available...
Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
Biology Products: